KBP Biosciences is looking to reclaim ownership of the ill-fated heart drug ocedurenone from Novo Nordisk following a botched $1.3 billion deal and ...
SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a recent decision by the Singapore International Commercial Court ("SICC"), which ...
A live audio webcast of Stifel presentation can be accessed through the Presentations section of KBP's investor relations website here. An archived replay of the webcast will be available on the ...
JINAN, China & PHILADELPHIA--(BUSINESS WIRE)--KBP Biosciences, a private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in ...
The utility of genomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. CEO Michael Kulp talks about the company's growth and what ...
FT’s Picks of the Week highlight notable C-suite moves, brand milestones, tech tidbits and other franchise news, sourced by the Franchise Times editorial team. KBP Brands acquired 78 corporate-owned ...
KBP Brands, one of the largest franchisee organizations in the U.S., just became even bigger. The 1,100-plus-unit group announced Monday that it acquired 78 more Sonic restaurants across Ohio, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results